Determinants of utilisation differences for cancer medicines in Belgium, Scotland and Sweden
Crossref DOI link: https://doi.org/10.1007/s10198-016-0855-5
Published Online: 2016-12-09
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ferrario, Alessandra
License valid from 2016-12-09